Begona Madariaga

Department Of R/D
Zamudio, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients - ARES observational study.

Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients - ARES observational study.

Journal: Expert review of clinical immunology
Published: June 27, 2024

Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy.

Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy.

Journal: European annals of allergy and clinical immunology
Published: April 01, 2020

Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational study.

Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational study.

Journal: Immunotherapy
Published: January 07, 2020

Clinical assessment of tolerability, immunological and cutaneous reactivity effects of an abbreviated schedule with Olea europaeanative extract of subcutaneous immunotherapy.

Clinical assessment of tolerability, immunological and cutaneous reactivity effects of an abbreviated schedule with Olea europaeanative extract of subcutaneous immunotherapy.

Journal: European annals of allergy and clinical immunology
Published: December 03, 2019

Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA).

Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA).

Journal: European annals of allergy and clinical immunology
Published: July 10, 2019

Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effect.

Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effect.

Journal: Immunotherapy
Published: June 26, 2019

Timothy grass pollen therapeutic vaccine: optimal dose for subcutaneous immunotherapy.

Timothy grass pollen therapeutic vaccine: optimal dose for subcutaneous immunotherapy.

Journal: Immunotherapy
Published: January 14, 2016

A Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelines.

A Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelines.

Journal: Immunotherapy
Published: April 29, 2015
Showing 1-8 of 8

Last Updated: 09/26/2026